Adrenal gland – Upk3b negative adrenocortical adenoma
Kidney – Upk3b negative clear cell carcinoma
Kidney – Upk3b negative papillary renal cell carcinoma
Liver - Upk3b negative hepatocellular carcinoma
Lung - Upk3b negative small cell carcinoma
Lung – Epitheloid mesothelioma with membranous Upk3b positivity of variable intensity in most tumor cells
Lung – Epitheloid mesothelioma with membranous Upk3b staining of variable intensity in most tumor cells
Lung – Epitheloid mesothelioma with moderate to strong membranous, predominantly apical Upk3b tumor cell positivity
Lung – Mesothelioma exhibiting a membranous Upk3b staining of variable intensity in most epitheloid tumor cells
Lung – Mesothelioma showing moderate to strong membranous, predominantly apical Upk3b positivity of epitheloid tumor cells
Lung – Mesothelioma with strong membranous, predominantly apical Upk3b positivity of epitheloid tumor cells
Lung – Upk3b negative adenocarcinoma (1)
Lung – Upk3b negative adenocarcinoma (2)
Lung – Upk3b negative adenocarcinoma (3)
Ovary – Serous high-grade carcinoma with strong membranous Upk3b immunostaining in a subset of tumor cells
Ovary – Serous high-grade carcinoma with strong membranous Upk3b staining in _80_ of tumor cells
Ovary – Serous high-grade carcinoma with strong membranous Upk3b staining of a subset of tumor cells
Ovary – Serous high-grade carcinoma with strong Upk3b positivity of luminal membranes of a fraction of tumor cells
Salivary gland – Upk3b negative Warthin tumor
Soft tissue – Upk3b negative leiomyosarcoma
Testis – Upk3b negative seminoma
Urinary bladder – Muscle-invasive urothelial carcinoma with predominantly membranous Upk3b positivity of variable intensity in most tumor cells
Urinary bladder – Muscle-invasive urothelial carcinoma with strong membranous Upk3b positivity of tumor cells, predominantly at luminal surface membranes
Urinary bladder – Muscle-invasive urothelial carcinoma with strong, predominantly membranous Upk3b immunostaining of most tumor cells
Urinary bladder – Upk3b negative small cell carcinoma